Urologic cancers refer to malignancies that arise in the organs of the urinary system and the male reproductive tract. These include cancers of the kidney, bladder, prostate, testicles, ureters, and urethra. Each type has unique characteristics, symptoms, and treatment protocols, but early diagnosis significantly improves outcomes.
Urologic cancers can affect both men and women, though some (like prostate and testicular cancer) are male-specific. A multidisciplinary approach—often involving nephrologists, urologists, oncologists, and radiologists—is key to effective management.
You should seek medical advice if you notice:
One of the best doctors I’ve met. Very knowledgeable and made me feel at ease from day one.
Yes. Many urologic cancers are highly treatable, especially when detected early. Treatment options vary from surgery and radiation to immunotherapy and targeted drugs.
Risk factors include smoking, prolonged exposure to certain chemicals, chronic urinary infections, genetic predisposition, and older age.
Routine screening through PSA blood tests and digital rectal examination (DRE) often leads to early detection.
Not always. It could also be due to infections or stones. However, it should never be ignored and must be evaluated promptly.
Yes. It is more common in younger males, typically between ages 15 to 35, and is highly curable if treated early.
Depending on the type and stage of cancer, some treatments may impact fertility, urinary control, or sexual function. Your care team will help you manage and minimize these effects.